Maya Hacini

580 total citations
15 papers, 358 citations indexed

About

Maya Hacini is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Maya Hacini has authored 15 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Maya Hacini's work include Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (4 papers) and Neutropenia and Cancer Infections (3 papers). Maya Hacini is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (4 papers) and Neutropenia and Cancer Infections (3 papers). Maya Hacini collaborates with scholars based in France, United States and Luxembourg. Maya Hacini's co-authors include Gilles Salles, Alain Delmer, Tony Petrella, Corinne Haïoun, Olivier Fitoussi, Serge Bologna, Hervé Tilly, A. Thyss, Richard Delarue and Loïc Ysebaert and has published in prestigious journals such as Blood, The Lancet Oncology and Journal of Hematology & Oncology.

In The Last Decade

Maya Hacini

14 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maya Hacini France 6 285 189 114 81 58 15 358
Sverker Hasselblom Sweden 14 320 1.1× 209 1.1× 115 1.0× 79 1.0× 35 0.6× 25 494
Florence Broussais‐Guillaumot France 9 228 0.8× 153 0.8× 95 0.8× 57 0.7× 16 0.3× 14 305
Jennifer L. Cultrera United States 8 182 0.6× 202 1.1× 80 0.7× 31 0.4× 25 0.4× 23 326
Alessia Castellino Italy 11 279 1.0× 180 1.0× 102 0.9× 143 1.8× 18 0.3× 34 356
Lynny Yung United Kingdom 5 227 0.8× 184 1.0× 55 0.5× 65 0.8× 14 0.2× 7 315
Emanuela Merla Italy 11 297 1.0× 143 0.8× 108 0.9× 83 1.0× 13 0.2× 17 390
S. Wiedenmann Germany 8 278 1.0× 182 1.0× 94 0.8× 94 1.2× 12 0.2× 8 350
Serafín Delgado Mexico 9 228 0.8× 152 0.8× 60 0.5× 126 1.6× 77 1.3× 12 334
Caroline Girouard Canada 9 168 0.6× 217 1.1× 51 0.4× 63 0.8× 103 1.8× 9 367
Marita Kloess Germany 7 265 0.9× 136 0.7× 121 1.1× 189 2.3× 15 0.3× 12 348

Countries citing papers authored by Maya Hacini

Since Specialization
Citations

This map shows the geographic impact of Maya Hacini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya Hacini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya Hacini more than expected).

Fields of papers citing papers by Maya Hacini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maya Hacini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya Hacini. The network helps show where Maya Hacini may publish in the future.

Co-authorship network of co-authors of Maya Hacini

This figure shows the co-authorship network connecting the top 25 collaborators of Maya Hacini. A scholar is included among the top collaborators of Maya Hacini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maya Hacini. Maya Hacini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rousselot, Philippe, Jean‐Christophe Ianotto, Philippe Quittet, et al.. (2024). Bosutinib for Patients with Previously Treated Chronic Myeloid Leukemia: Results from the French Observational Boseval Study. Blood. 144(Supplement 1). 3150–3150.
2.
3.
Sesques, Pierre, Jessie Bourcier, Camille Golfier, et al.. (2020). Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era. Hematological Oncology. 38(2). 137–145. 4 indexed citations
4.
Rosé, Christian, Emmanuel Gyan, Maya Hacini, et al.. (2018). Prospective evaluation of the effect of deferasirox on hematologic response in transfusion‐dependent patients with low‐risk MDS and iron overload. European Journal Of Haematology. 101(2). 165–173. 7 indexed citations
5.
Damaj, Gandhi, et al.. (2017). ZOHé: A Prospective Study of the Use of Biosimilar Filgrastim Zarzio in Clinical Practice in Patients Treated With Chemotherapy for Lymphoid Malignancies. Clinical Lymphoma Myeloma & Leukemia. 17(6). 362–369.e2. 5 indexed citations
6.
Chaoui, Driss, Sylvain Choquet, Laurence Sanhès, et al.. (2017). Relapsed chronic lymphocytic leukemia retreated with rituximab: interim results of the PERLE study. Leukemia & lymphoma. 58(6). 1366–1375. 3 indexed citations
7.
Sarkozy, Clémentine, Sarah Huet, Victoria Carlton, et al.. (2017). The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma. Oncotarget. 8(5). 8765–8774. 70 indexed citations
8.
Gay, Valérie, et al.. (2016). Myelofibrosis and acquired hemophilia A: a case report. Journal of Medical Case Reports. 10(1). 115–115. 5 indexed citations
9.
Rosé, Christian, Olivier Fitoussi, Emmanuel Gyan, et al.. (2016). Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload: The Rythmex Study. Blood. 128(22). 2008–2008. 7 indexed citations
10.
11.
Delarue, Richard, Hervé Tilly, Nicolas Mounier, et al.. (2013). Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial. The Lancet Oncology. 14(6). 525–533. 205 indexed citations
12.
Chauchet, Adrien, Anne‐Sophie Michallet, Françoise Berger, et al.. (2012). Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma. Journal of Hematology & Oncology. 5(1). 27–27. 29 indexed citations
13.
Chauchet, Adrien, Anne‐Sophie Michallet, Françoise Berger, et al.. (2011). Complete Remission After First-Line Radio Plus Chemotherapy Is Enough to Improve Survival in Extra Nodal NK/T Cell lymphoma. Blood. 118(21). 2679–2679. 1 indexed citations
14.
15.
Thuret, Isabelle, et al.. (2009). Socio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results. Hematology. 14(6). 315–322. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sverker Hasselblom Breakdown of academic impact, for papers by Florence Broussais‐Guillaumot Breakdown of academic impact, for papers by Jennifer L. Cultrera Breakdown of academic impact, for papers by Alessia Castellino Breakdown of academic impact, for papers by Lynny Yung Breakdown of academic impact, for papers by Emanuela Merla Breakdown of academic impact, for papers by S. Wiedenmann Breakdown of academic impact, for papers by Serafín Delgado Breakdown of academic impact, for papers by Caroline Girouard Breakdown of academic impact, for papers by Marita Kloess
Rankless by CCL
2026